5,056 results on '"Martinelli, Giovanni"'
Search Results
252. Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia
253. Fall Predictors in Hospitalized Patients Living with Cancer: A Case-Control Study
254. A Preliminary Assessment of Young Water Fractions in Groundwater from Alluvial Aquifers Facing the Northern Italian Apennines
255. Abstract P2-13-44: HDAC6 is an unfavorable prognostic factor in HER2-positive breast cancer patients treated with adjuvant trastuzumab
256. Abstract P5-06-04: A multi-omics approach to study the host-microbiota interaction in breast cancer tissue
257. Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt–Hogg–Dubè Syndrome Family
258. Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia
259. Fluid expulsion in terrestrial sedimentary basins: A process providing potential analogs for giant polygons and mounds in the martian lowlands
260. Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
261. On the possible origin of thermal infrared radiation (TIR) anomalies in earthquake-prone areas observed using robust satellite techniques (RST)
262. Circulating Endothelial Cells as a Novel Marker of Angiogenesis
263. Follow-up of Patients With FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukaemia in the Phase 3 ADMIRAL Trial
264. Additional file 1 of CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
265. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (vol 13, 2, 2022)
266. A population‐based study of chronic myeloid leukemia patients treated with imatinib in first line
267. Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
268. Who should be really considered as a poor mobilizer in the plerixafor era?
269. Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase
270. Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis
271. Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
272. High grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma
273. Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid Leukemia
274. Single Nucleotide Polymorphisms as Genomic Markers for High-Throughput Pharmacogenomic Studies
275. Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences
276. Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia
277. Mud Flow Dynamics at Gas Seeps (Nirano Salse, Italy)
278. An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study
279. Editorial: Achievements and New Frontiers in Research Oriented to Earthquake Forecasting
280. Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
281. Unravelling similarities and differences in the role of circular and linear PVT1 in cancer and human disease
282. A Phase 1b/2 Study of the CD123-Targeting Antibody-Drug Conjugate IMGN632 As Monotherapy or in Combination with Venetoclax and Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia
283. Role of Pegfilgrastim in the Supportive Care of Heavily Pretreated Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone
284. Impact of Comorbidities on Prognosis of Elderly Patients with Acute Myeloid Leukemia Who Receive Hypomethylating Agents
285. Erythropoiesis Stimulating Agents (ESAS) in Supportive Care of Low-Risk Myelodysplastic Syndromes: Recamds Registry FINAL Results
286. INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
287. Dissecting the Adaptive Response to Arginine Deprivation in Hodgkin Lymphoma
288. Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
289. Results of the 6-Year Follow-up of the Gimema AML1310 Trial: A Risk-Adapted, MRD-Directed Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia
290. IDH1/2 Mutations Are Maintained in a Subset of Patients with Acute Myeloid Leukemia in Complete Remission and Do Not Correlate with Residual Disease
291. A Study of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, for Patients with Frontline and Relapsed/Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
292. Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma: Old PLUS New Drugs in NOVEL Agents' Era
293. Experience with IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Frontline Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
294. Carfilzomib-Lenalidomide-Dexamethasone in the Management of Lenalidomide-Refractory Multiple Myeloma
295. Safety and Efficacy from a Phase 1b/2 Study of IMGN632 in Combination with Azacitidine and Venetoclax for Patients with CD123-Positive Acute Myeloid Leukemia
296. Geofluids Hosted in the Deep Crust: From Systematics to Parametrization of their Significance
297. TARGETED THERAPY IN AML TREATMENT
298. 126. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination
299. Haematological Support: Progenitor Cell Collection and Processing
300. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.